Isobionics Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 7

Isobionics General Information

Description

Developer of natural ingredients intended for the flavors and fragrances. The company provides isoprenoids based ingredients using its proprietary platform technology which transfers sugar, solved in water, into Valencene (Orange) or other natural compounds in a fermentation vessel for the flavor and fragrance, agrochemical and pharmaceutical markets.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Multi-line Chemicals
Primary Office
  • Urmonderbaan 22
  • Building 45 (level 1)
  • 6167 RD Geleen
  • Netherlands
+31 043 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Isobionics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isobionics‘s full profile, request access.

Request a free trial

Isobionics Executive Team (6)

Name Title Board Seat Contact Info
Ton van Manen Director of Product Development
Theo Sonke Project Director Biotechnology
Toine Janssen Founder, Chief Executive Officer & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

Isobionics Board Members (6)

Name Representing Role Since
00000 0000000 Self Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 1 of 6 board members. Get the full list »

Isobionics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Isobionics‘s full profile, request access.

Request a free trial